Zeev Bronfeld - Director at Protalix BioTherapeutics, Inc.

Insider Transactions and Holdings

Identity
Entity type
Individual
Role
Director
Issuer context
Issuer symbol
PLX on NYSE
SEC evidence
Source filings
Open source filing history

There are no Buy or Sell transactions made by Zeev Bronfeld since 01 Jun 2025

Holdings reported by Zeev Bronfeld for Protalix BioTherapeutics, Inc.

Form 4 holding Director

Protalix BioTherapeutics, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
100,000
Estimated value
Report date
07 Sep 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Zeev Bronfeld for Protalix BioTherapeutics, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .